Patient advisory board
The Patient Advisory Board will continue its activities as part of the National Network for the Development of Pharmacotherapy.
New organizations may join the network in late 2026. Information about the application process and membership opportunities will be communicated through a news article on Fimea’s website and via the development network’s newsletter.
Website of National network for the development of the pharmacotherapy
Subscribe to National network for the development of the pharmacotherapy newsletter
(in Finnish, the form is in Finnish).
Further information:
Carita Lindén-Lahti, Development Specialist, tel. +358 29 522 3128